What’s coming for the healthcare sector in 2020, and more importantly, what do pharma, medical device, and healthcare delivery executives need to do to succeed?
More InsightsHealthcare Delivery and Payers Pharmaceuticals and Medical Devices
- Healthcare Delivery and Payers
- Pharmaceuticals and Medical Devices
As the US heads into an election year, healthcare will be in the spotlight as never before. We expect both parties will be under pressure to propose solutions that appear substantive without threatening benefits that many consumers value. The current administration is likely to continue its incremental steps toward a…
As our Numerof 2020 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about adapting to pressures on price and demands for value. You’ll continue to engage in new and different ways with regulators, public and private payers, consumers, employers, health care delivery, physicians,…
As our Numerof 2020 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value. This will create the need for changes in current roles and external relationships. You’ll continue to engage in new and different…
As our Numerof 2020 US Health Insurance Outlook infographic illustrates, this year’s story for health insurance will be about dramatically changing roles and relationships. You’ll engage in new and different ways with providers, consumers, employers, regulators, medical device makers and pharmaceutical manufacturers. All this will come in the context of…
Numerof’s annual State of Population Health Survey is fast becoming the benchmark for change in healthcare delivery. Our fourth annual report reflects input from more than 500 executives across the country. To see some of the most important takeaways, download our Population Health Insights infographic.